IκBζ is a regulator of the senescence-associated secretory phenotype in DNA damage- and oncogene-induced senescence

Journal of Cell Science

Volumn 126, Issue 16, 2013, Pages 3738-3745

  Alexander, Eva ^a   Hildebrand, Dominic G ^a   Kriebs, Anna ^a   Obermayer, Kerstin ^a   Manz, Marianne ^a   Rothfuss, Oliver ^a   Schulze Osthoff, Klaus ^a,b   Essmann, Frank ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cytokines; DNA damage; I B ; NF B; SASP; Senescence

Indexed keywords

I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN P21;

ARTICLE; CONTROLLED STUDY; DNA DAMAGE; GENE SILENCING; HUMAN; HUMAN CELL; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SENESCENCE;

CYTOKINES; DNA DAMAGE; IΚBΖ; NFΚB; SASP; SENESCENCE;

CELL AGING; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CYTOKINES; DNA DAMAGE; HUMANS; I-KAPPA B PROTEINS; MCF-7 CELLS; ONCOGENES; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 84883444868     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.128835     Document Type: Article

References (47)

1. Acosta, J. C. and Gil, J. (2012). Senescence: a new weapon for cancer therapy. Trends Cell Biol. 22, 211-219.
2. Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N. et al. (2008). Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006-1018.
3. Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K. and Akira, S. (1998). Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143-150.
4. Adams, P. D. (2007). Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 397, 84-93.
5. Adams, P. D. (2009). Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol. Cell 36, 2-14.
6. Campisi, J. (2013). Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 75, 685-705.
7. Chien, Y., Scuoppo, C., Wang, X., Fang, X., Balgley, B., Bolden, J. E., Premsrirut, P., Luo, W., Chicas, A., Lee, C. S. et al. (2011). Control of the senescence-associated secretory phenotype by NF-kB promotes senescence and enhances chemosensitivity. Genes Dev. 25, 2125-2136.
8. Coppé, J. P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P. Y. and Campisi, J. (2008). Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853-2868.
9. Coppé, J. P., Desprez, P. Y., Krtolica, A. and Campisi, J. (2010). The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99-118.
10. Deshmane, S. L., Kremlev, S., Amini, S. and Sawaya, B. E. (2009). Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 29, 313-326.
11. Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., Pereira-Smith, O. et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92, 9363-9367.
12. Dinarello, C. A., Simon, A. and van der Meer, J. W. (2012). Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 11, 633-652.
13. Essmann, F., Pohlmann, S., Gillissen, B., Daniel, P. T., Schulze-Osthoff, K. and Jänicke, R. U. (2005). Irradiation-induced translocation of p53 to mitochondria in the absence of apoptosis. J. Biol. Chem. 280, 37169-37177.
14. Freund, A., Patil, C. K. and Campisi, J. (2011). p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J. 30, 1536-1548.
15. Gay, N. J., Gangloff, M. and O'Neill, L. A. (2011). What the Myddosome structure tells us about the initiation of innate immunity. Trends Immunol. 32, 104-109.
16. Graupner, V., Alexander, E., Overkamp, T., Rothfuss, O., De Laurenzi, V., Gillissen, B. F., Daniel, P. T., Schulze-Osthoff, K. and Essmann, F. (2011). Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level. Cell Death Differ. 18, 1130-1139.
17. Hildebrand, D. G., Alexander, E., Hörber, S., Lehle, S., Obermayer, K., Münck, N. A., Rothfuss, O., Frick, J.-S., Morimatsu, M., Schmitz, I. et al. (2013). IkBf is a transcriptional key regulator of CCL2/MCP-1. J. Immunol. 190, 4812-4820.
18. Hinz, M., Stilmann, M., Arslan, S. C., Khanna, K. K., Dittmar, G. and Scheidereit, C. (2010). A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-kB activation. Mol. Cell 40, 63-74.
19. Hoenicke, L. and Zender, L. (2012). Immune surveillance of senescent cells- biological significance in cancer- and non-cancer pathologies. Carcinogenesis 33, 1123-1126.
20. Jing, H., Kase, J., Dörr, J. R., Milanovic, M., Lenze, D., Grau, M., Beuster, G., Ji, S., Reimann, M., Lenz, P. et al. (2011). Opposing roles of NF-kB in anti-cancer treatment outcome unveiled by cross-species investigations. Genes Dev. 25, 2137-2146.
21. Kang, T. W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A. et al. (2011). Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547-551.
22. Kayama, H., Ramirez-Carrozzi, V. R., Yamamoto, M., Mizutani, T., Kuwata, H., Iba, H., Matsumoto, M., Honda, K., Smale, S. T. and Takeda, K. (2008). Classs-pecific regulation of pro-inflammatory genes by MyD88 pathways and IkappaBzeta. J. Biol. Chem. 283, 12468-12477.
23. Kitamura, H., Kanehira, K., Okita, K., Morimatsu, M. and Saito, M. (2000). MAIL, a novel nuclear I kappa B protein that potentiates LPS-induced IL-6 production. FEBS Lett. 485, 53-56.
24. Krtolica, A., Parrinello, S., Lockett, S., Desprez, P. Y. and Campisi, J. (2001). Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. USA 98, 12072-12077.
25. Kuilman, T. and Peeper, D. S. (2009). Senescence-messaging secretome: SMS-ing cellular stress. Nat. Rev. Cancer 9, 81-94.
26. Kuilman, T., Michaloglou, C., Vredeveld, L. C., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J. and Peeper, D. S. (2008). Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019-1031.
27. Kuilman, T., Michaloglou, C., Mooi, W. J. and Peeper, D. S. (2010). The essence of senescence. Genes Dev. 24, 2463-2479.
28. Liu, F., Wu, S., Ren, H. and Gu, J. (2011). Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat. Cell Biol. 13, 254-262.
29. Meerbrey, K. L., Hu, G., Kessler, J. D., Roarty, K., Li, M. Z., Fang, J. E., Herschkowitz, J. I., Burrows, A. E., Ciccia, A., Sun, T. et al. (2011). The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc. Natl. Acad. Sci. USA 108, 3665-3670.
30. Miyamoto, S. (2011). Nuclear initiated NF-kB signaling: NEMO and ATM take center stage. Cell Res. 21, 116-130.
31. Narita, M., Nũnez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J. and Lowe, S. W. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703-716.
32. Oeckinghaus, A., Hayden, M. S. and Ghosh, S. (2011). Crosstalk in NF-kB signaling pathways. Nat. Immunol. 12, 695-708.
33. Ohanna, M., Giuliano, S., Bonet, C., Imbert, V., Hofman, V., Zangari, J., Bille, K., Robert, C., Bressac-de Paillerets, B., Hofman, P. et al. (2011). Senescent cells develop a PARP-1 and nuclear factor-kappaB-associated secretome (PNAS). Genes Dev. 25, 1245-1261.
34. Orjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K. and Campisi, J. (2009). Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc. Natl. Acad. Sci. USA 106, 17031-17036.
35. Perkins, N. D. (2012). The diverse and complex roles of NF-kB subunits in cancer. Nat. Rev. Cancer 12, 121-132.
36. Rodier, F., Coppé, J. P., Patil, C. K., Hoeijmakers, W. A., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R. and Campisi, J. (2009). Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 11, 973-979.
37. Rovillain, E., Mansfield, L., Caetano, C., Alvarez-Fernandez, M., Caballero, O. L., Medema, R. H., Hummerich, H. and Jat, P. S. (2011). Activation of nuclear factor-kappa B signalling promotes cellular senescence. Oncogene 30, 2356-2366.
38. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. and Lowe, S. W. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602.
39. Seshadri, S., Kannan, Y., Mitra, S., Parker-Barnes, J. and Wewers, M. D. (2009). MAIL regulates human monocyte IL-6 production. J. Immunol. 183, 5358-5368.
40. Shiina, T., Konno, A., Oonuma, T., Kitamura, H., Imaoka, K., Takeda, N., Todokoro, K. and Morimatsu, M. (2004). Targeted disruption of MAIL, a nuclear IkappaB protein, leads to severe atopic dermatitis-like disease. J. Biol. Chem. 279, 55493-55498.
41. Smale, S. T. (2011). Hierarchies of NF-kB target-gene regulation. Nat. Immunol. 12, 689-694.
42. Sulli, G., Di Micco, R. and d'Adda di Fagagna, F. (2012). Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer. Nat. Rev. Cancer 12, 709-720.
43. Totzke, G., Essmann, F., Pohlmann, S., Lindenblatt, C., Jänicke, R. U. and Schulze-Osthoff, K. (2006). A novel member of the IkappaB family, human IkappaB-zeta, inhibits transactivation of p65 and its DNA binding. J. Biol. Chem. 281, 12645-12654.
44. Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C. and Lowe, S. W. (2007). Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656-660.
45. Yamamoto, M., Yamazaki, S., Uematsu, S., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Kuwata, H., Takeuchi, O., Takeshige, K. et al. (2004). Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 430, 218-222.
46. Yamazaki, S., Muta, T. and Takeshige, K. (2001). A novel IkappaB protein, IkappaB-zeta, induced by proinflammatory stimuli, negatively regulates nuclear factor-kappaB in the nuclei. J. Biol. Chem. 276, 27657-27662.
47. Yamazaki, S., Matsuo, S., Muta, T., Yamamoto, M., Akira, S. and Takeshige, K. (2008). Gene-specific requirement of a nuclear protein, IkappaB-zeta, for promoter association of inflammatory transcription regulators. J. Biol. Chem. 283, 32404-32411.